As the global population grows and dietary habits change in accordance with economic development in emerging countries, worldwide protein demand is expected to increase substantially in the future. There are forecasts that the balance of protein supply and demand will collapse as early as in 2030.


In recent years, Algae is expected to play a role as an alternative to plant-based protein. 

Algae can grow by photosynthesis alone, and has significant high productivity per unit area compared to other protein sources such as vegetables and meat. That is how we have come to focus on Fresh-water algae spirulina.With its high protein content (over 65% on a dry weight basis) and nutritional value such as rich in vitamins, minerals, and fibers, spirulina has been hailed as 'superfood.'


Tabérumo Corp. is one business entity of a group of biotech companies, the “Chitose Group”. Odorless fresh taste raw Spirulina is produced and commercialized using the efficient cultivation technologies developed by Chitose Laboratory Corp., which is the research entity of Chitose Group. In addition, in order to use spirulina as a protein source in various food products, our unique and original technologies have been developed and applied for product development, commercialization, and marketing.


Tabérumo Corp. has been receiving capital injection from The Innovation Network Corporation of Japan (INCJ), a Japanese Government fund and Mitsubishi Corporation since  May 2018.

Tabérumo Corp.
President and Managing Director
Toshiya Sasaki Ph.D.
July 25th, 2014
Business overview
Developing cultivation technologies and new applications of Spirulina for its commercial production and marketing
The Innovation Network Corporation of Japan (INCJ)
Mitsubishi Corporation
Kanagawa Science Park EASST 511
3-2-1, Sakado, Takatsu-ku, Kawasaki, Kanagawa, Japan